Article
Network Pharmacology Prediction and Experimental Validation of Apocynin Against Colon Adenocarcinoma: Identification of CCND1 and CXCL8 as Key Targets
2026-06-08
Abstract excerpt
<title>Abstract</title> <p>Background Colon adenocarcinoma (COAD) remains a leading cause of cancer-related mortality, necessitating novel therapeutic strategies. Apocynin, a natural NADPH oxidase inhibitor, exhibits anti-tumor potential, yet its precise mechanisms against COAD remain poorly characterized. Methods An integrative approach combining, bioinformatics, molecular docking, and in vitro experimental va...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6d7454db-acf6-5187-b68d-56f6d43f6b52
- DOI
- 10.21203/rs.3.rs-9841007/v1
